Skip to content

Clinical Observation of the Therapeutic Effect of Minimally Invasive Annulus Fibrosus Repair for Lumbar Disc Herniation

Clinical Observation of the Therapeutic Effect of Minimally Invasive Annulus Fibrosus Repair for Lumbar Disc Herniation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500106657
Enrollment
Unknown
Registered
2025-07-28
Start date
2025-07-31
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Herniated lumbar disc

Interventions

control group:Minimally invasive spinal disc removal surgery
experimental group:Minimally invasive spinal disc nucleotomy and annulus fibrosus suture

Sponsors

Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Age 18–80 years (including 18 and 80 years), no gender restrictions; (2) Meets Western medical diagnostic criteria for LDH; (3) Ineligible for surgical treatment after 3 months of conservative treatment; (4) Accurate and complete clinical data; (5) Anesthesia classification: Grade I–II; (6) CT scan shows no significant calcification or ossification, with the affected segment exhibiting a soft protrusion; after discectomy, the residual defect of the annulus fibrosus is <10 mm; (7) First-time surgical treatment, single-segment involvement; (8) Voluntarily participates in this trial and signs an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with malignant tumors, immune disorders, or hematological diseases; (2) Patients with a history of lumbar spine surgery; those with concomitant lumbar spine deformities, fractures, spondylolisthesis, endplate inflammation, or other lumbar spine conditions; (3) Patients with psychiatric disorders or cognitive impairments who cannot cooperate with the study; (4) Patients with severe impairment or failure of liver or kidney function; (5) Pregnant or breastfeeding women.

Design outcomes

Primary

MeasureTime frame
Recurrence rate;

Secondary

MeasureTime frame
Visual analogue scale;Oswestry dysfunction index;Spinal cord nerve function;

Countries

China

Contacts

Public ContactRigao Chen

Affiliated Hospital of Chengdu University of Traditional Chinese Medicine

4118510@qq.com+86 138 8045 0622

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026